Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fuzeon Early Access Program in Advanced HIV
NCT00050856Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2002
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of enfuvirtide in human immunodeficiency virus type 1 infection (HIV-1), sponsored by National Institute of Allergy and Infectious Diseases. Started Nov 2002; status: completed.
02
Drugs
enfuvirtide
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00050856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00050856.